Product Information

BEPOTASTINE 1.5% EYE DROP is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $8.3591 per ML under NDC 00378705567. Its NADAC has been published 262 times since Aug 18, 2021.

FDA first approved this application on Mar 18, 2019. Its Orange Book therapeutic-equivalence code is AT.

BEPOTASTINE 1.5% EYE DROP

Bepotastine Besilate
$8.3591per ML

Strength

15 mg/mL

NDC

00378705567

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

BEPOTASTINE BESILATE

Approval Type

Generic (ANDA)

FDA Application

ANDA206220

FDA Approved

3/18/2019

TE Code

AT

On Market Since

5/28/2021

Pharmacological Classes

Price Statistics

The NADAC for BEPOTASTINE 1.5% EYE DROP has been published 262 times since Aug 18, 2021, and over the history we have for it it has declined 76.8%. The table below summarizes its recorded NADAC range and movement.

Current price$8.3591 per ML
All-time high$36.0376 (Dec 15, 2021)
All-time low$8.3145 (Jul 22, 2026)
52-week high$16.1322
52-week low$8.3145
Median price$18.2162
Average price$20.2935
Largest weekly change-29.4% (May 18, 2022)
Weeks tracked262
Tracking sinceAug 18, 2021

Price History

1W

+0.5%

1M

+0.5%

3M

-10.6%

6M

-41.9%

1Y

-48.2%

3Y

-61.0%

5Y

-76.8%

All

-76.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BEPOTASTINE 1.5% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for BEPOTASTINE 1.5% EYE DROP, manufactured by Mylan Pharmaceuticals Inc., is $8.3591 per ML (NDC 00378705567), effective Aug 19, 2026.

How has the price of BEPOTASTINE 1.5% EYE DROP changed over time?

Over the history we have for it, the NADAC for BEPOTASTINE 1.5% EYE DROP has declined 76.8%. It has been tracked across 262 weekly CMS publications since Aug 18, 2021.

What are the highest and lowest recorded NADAC prices for BEPOTASTINE 1.5% EYE DROP?

Since Aug 18, 2021, the NADAC for BEPOTASTINE 1.5% EYE DROP has ranged from a low of $8.3145 (Jul 22, 2026) to a high of $36.0376 (Dec 15, 2021), with a median of $18.2162 per ML.

Are there cheaper alternatives to BEPOTASTINE 1.5% EYE DROP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BEPOTASTINE 1.5% EYE DROP in a comparable dosage form, but none are currently priced below it.

Who manufactures BEPOTASTINE 1.5% EYE DROP?

BEPOTASTINE 1.5% EYE DROP (NDC 00378705567) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.